financetom
Market
financetom
/
Market
/
Bank Nifty uptrend intact as long as SBI above Rs 214: Jai Bala
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bank Nifty uptrend intact as long as SBI above Rs 214: Jai Bala
Nov 10, 2020 4:47 AM

Jai Bala of cashthechaos.com sees a resistance at 12,750-12,790 on the Nifty.

“If the markets were to not go above that, I think we are registering the possibility of a short term buying exhaustion,” he said in an interview to CNBC-TV18.

“So, this short term could also materialise over several weeks. Keep your stops tight if you are long in the market,” he said.

Bala said Reliance Industries, banking, IT, and pharmaceutical are the four legs supporting the rally.

“If any of these were to succumb to selling pressure at current levels, the market could face short term correction,” he said.

On the banking index, Bala believes that HDFC Bank and SBI are going to be crucial for trend continuation. The major resistance for the Bank Nifty is at 28,500 and 29,600, he said.

“SBI might be the bellwether for the banking index. As long as SBI is above Rs 214 there may not be a warning sign for the index. But if SBI were below Rs 214, then that is a major warning sign for the whole sector,” he said.

According to Bala, the pharma index is holding the important support level of 11,000.

However, Bala is unsure about Nifty IT holding up. “It might be on next leg move to 26,000, but if today’s low were to break, somewhere between 21,100 and 25,000, that is the key level for Nifty IT index. If that were to break, that is another factor for us to consider for us to book profits and wait for a short term correction to play out,” he said.

Bala is positive on Avanti Feed and EIH from the midcap space.

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

(Edited by : Santosh Nair)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved